In order to obtain intravenous immunoglobulin G (iv IgG) of high quality from F-I+II+III or F-II+III pastes prepared by the Cohn method, we developed a chromatography process using ion exchange gels, Q-Sepharose FF and CM-Sepharose FF, and Sephacryl S-300 gel filtration. Viral inactivation was performed by incubating the preparation with pepsin at pH 4.0 at 35oC for 18 h. The characteristics of 28 batches produced by us were: yield 4.3 ± 0.2 g/l plasma, i.e., a recovery of 39.1 ± 1.8%; IgG subclasses distribution: IgG1 = 58.4%, IgG2 = 34.8%, IgG3 = 4.5% and IgG4 = 2.3%; IgG size distribution was 98.4% monomers, 1.2% dimers and 0.4% polymers and protein aggregates; anticomplement activity was less than 0.5 CH50/mg IgG, and prekallikrein acti...
Human immunoglobulin (Ig) began to be applied in the clinical practice with the treatment of primary...
Agarose gels with immobilized amine-based ligands L-lysine (Lys) and poly-L-lysine (PLL) exhibited t...
Three not yet commercially available immunoglobulin preparations, intended for intravenous administr...
In order to obtain intravenous immunoglobulin G (iv IgG) of high quality from F-I+II+III or F-II+III...
Immunoglobulin G (IgG) of excellent quality for intravenous use was obtained from the cryosupernatan...
The aim of this research project is to develop a new chromatography-based manufacturing process of a...
Large volumes of plasma can be fractionated by the method of Cohn at low cost. However, liquid chrom...
Polyvalent immunoglobulin G (IgG) products obtained by fractionation of human plasma are widely used...
Based on European Pharmacopeia, there are some features which should be measured for any intravenous...
The first purified human immunoglobulin G (IgG) preparation used clinically was im-mune serum globul...
Summary: Heat treatment of human plasma at 56 °C eliminates an unstable immunoglobulin fraction. No ...
Using a combined procedure of polyethilene glycol precipitation and ion exchange chromatography it w...
immunoglobulin G (IgG) containing a standardized amount of antibody to Cytomegalovirus (CMV). CMV-IG...
Antibodies are biologically active proteins produced by plasma cells in response to the presence of ...
Anion exchange chromatography is widely accepted method for purification of immunoglobulins. In thi...
Human immunoglobulin (Ig) began to be applied in the clinical practice with the treatment of primary...
Agarose gels with immobilized amine-based ligands L-lysine (Lys) and poly-L-lysine (PLL) exhibited t...
Three not yet commercially available immunoglobulin preparations, intended for intravenous administr...
In order to obtain intravenous immunoglobulin G (iv IgG) of high quality from F-I+II+III or F-II+III...
Immunoglobulin G (IgG) of excellent quality for intravenous use was obtained from the cryosupernatan...
The aim of this research project is to develop a new chromatography-based manufacturing process of a...
Large volumes of plasma can be fractionated by the method of Cohn at low cost. However, liquid chrom...
Polyvalent immunoglobulin G (IgG) products obtained by fractionation of human plasma are widely used...
Based on European Pharmacopeia, there are some features which should be measured for any intravenous...
The first purified human immunoglobulin G (IgG) preparation used clinically was im-mune serum globul...
Summary: Heat treatment of human plasma at 56 °C eliminates an unstable immunoglobulin fraction. No ...
Using a combined procedure of polyethilene glycol precipitation and ion exchange chromatography it w...
immunoglobulin G (IgG) containing a standardized amount of antibody to Cytomegalovirus (CMV). CMV-IG...
Antibodies are biologically active proteins produced by plasma cells in response to the presence of ...
Anion exchange chromatography is widely accepted method for purification of immunoglobulins. In thi...
Human immunoglobulin (Ig) began to be applied in the clinical practice with the treatment of primary...
Agarose gels with immobilized amine-based ligands L-lysine (Lys) and poly-L-lysine (PLL) exhibited t...
Three not yet commercially available immunoglobulin preparations, intended for intravenous administr...